nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—bone cancer	0.907	1	CbGaD
Alfuzosin—Coronary artery disease—Cisplatin—bone cancer	0.00334	0.0358	CcSEcCtD
Alfuzosin—Infection—Carboplatin—bone cancer	0.0016	0.0171	CcSEcCtD
Alfuzosin—Liver injury—Cisplatin—bone cancer	0.00157	0.0168	CcSEcCtD
Alfuzosin—Pain—Carboplatin—bone cancer	0.00137	0.0147	CcSEcCtD
Alfuzosin—Hepatocellular injury—Cisplatin—bone cancer	0.00132	0.0142	CcSEcCtD
Alfuzosin—Neuropathy—Cisplatin—bone cancer	0.00124	0.0133	CcSEcCtD
Alfuzosin—Neuralgia—Epirubicin—bone cancer	0.000976	0.0105	CcSEcCtD
Alfuzosin—Laryngitis—Epirubicin—bone cancer	0.000941	0.0101	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Epirubicin—bone cancer	0.000916	0.00983	CcSEcCtD
Alfuzosin—Neuralgia—Doxorubicin—bone cancer	0.000903	0.00969	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Cisplatin—bone cancer	0.000876	0.00939	CcSEcCtD
Alfuzosin—Laryngitis—Doxorubicin—bone cancer	0.000871	0.00934	CcSEcCtD
Alfuzosin—Breast disorder—Cisplatin—bone cancer	0.000866	0.00929	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Doxorubicin—bone cancer	0.000848	0.0091	CcSEcCtD
Alfuzosin—Liver injury—Epirubicin—bone cancer	0.000806	0.00865	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Epirubicin—bone cancer	0.000772	0.00828	CcSEcCtD
Alfuzosin—Arthropathy—Epirubicin—bone cancer	0.000746	0.008	CcSEcCtD
Alfuzosin—Liver injury—Doxorubicin—bone cancer	0.000746	0.008	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Cisplatin—bone cancer	0.000724	0.00777	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Doxorubicin—bone cancer	0.000714	0.00766	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Cisplatin—bone cancer	0.000699	0.0075	CcSEcCtD
Alfuzosin—Arthropathy—Doxorubicin—bone cancer	0.00069	0.0074	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Epirubicin—bone cancer	0.000678	0.00728	CcSEcCtD
Alfuzosin—Hepatocellular injury—Epirubicin—bone cancer	0.000678	0.00728	CcSEcCtD
Alfuzosin—Influenza like illness—Epirubicin—bone cancer	0.000659	0.00707	CcSEcCtD
Alfuzosin—Urinary tract disorder—Cisplatin—bone cancer	0.000655	0.00703	CcSEcCtD
Alfuzosin—Connective tissue disorder—Cisplatin—bone cancer	0.000652	0.00699	CcSEcCtD
Alfuzosin—Urethral disorder—Cisplatin—bone cancer	0.00065	0.00697	CcSEcCtD
Alfuzosin—Neuropathy—Epirubicin—bone cancer	0.000637	0.00683	CcSEcCtD
Alfuzosin—Hepatocellular injury—Doxorubicin—bone cancer	0.000628	0.00673	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Doxorubicin—bone cancer	0.000628	0.00673	CcSEcCtD
Alfuzosin—Eye disorder—Cisplatin—bone cancer	0.00062	0.00665	CcSEcCtD
Alfuzosin—Cardiac disorder—Cisplatin—bone cancer	0.000616	0.0066	CcSEcCtD
Alfuzosin—Flushing—Cisplatin—bone cancer	0.000616	0.0066	CcSEcCtD
Alfuzosin—Influenza like illness—Doxorubicin—bone cancer	0.000609	0.00654	CcSEcCtD
Alfuzosin—Mediastinal disorder—Cisplatin—bone cancer	0.000598	0.00641	CcSEcCtD
Alfuzosin—Neuropathy—Doxorubicin—bone cancer	0.000589	0.00632	CcSEcCtD
Alfuzosin—Ill-defined disorder—Cisplatin—bone cancer	0.000536	0.00575	CcSEcCtD
Alfuzosin—Osteoarthritis—Methotrexate—bone cancer	0.000526	0.00564	CcSEcCtD
Alfuzosin—Malaise—Cisplatin—bone cancer	0.000521	0.00559	CcSEcCtD
Alfuzosin—Osteoarthritis—Epirubicin—bone cancer	0.000492	0.00528	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000488	0.00524	CcSEcCtD
Alfuzosin—Discomfort—Cisplatin—bone cancer	0.000486	0.00521	CcSEcCtD
Alfuzosin—Breast disorder—Methotrexate—bone cancer	0.000475	0.0051	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000474	0.00508	CcSEcCtD
Alfuzosin—Oedema—Cisplatin—bone cancer	0.000471	0.00505	CcSEcCtD
Alfuzosin—Infection—Cisplatin—bone cancer	0.000468	0.00502	CcSEcCtD
Alfuzosin—Nervous system disorder—Cisplatin—bone cancer	0.000462	0.00496	CcSEcCtD
Alfuzosin—Thrombocytopenia—Cisplatin—bone cancer	0.000461	0.00495	CcSEcCtD
Alfuzosin—Tachycardia—Cisplatin—bone cancer	0.00046	0.00493	CcSEcCtD
Alfuzosin—Skin disorder—Cisplatin—bone cancer	0.000458	0.00491	CcSEcCtD
Alfuzosin—Osteoarthritis—Doxorubicin—bone cancer	0.000456	0.00489	CcSEcCtD
Alfuzosin—Hyperhidrosis—Cisplatin—bone cancer	0.000456	0.00489	CcSEcCtD
Alfuzosin—Abdominal pain upper—Epirubicin—bone cancer	0.00045	0.00482	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Epirubicin—bone cancer	0.00045	0.00482	CcSEcCtD
Alfuzosin—Breast disorder—Epirubicin—bone cancer	0.000445	0.00477	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000443	0.00476	CcSEcCtD
Alfuzosin—Hypotension—Cisplatin—bone cancer	0.00044	0.00472	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000429	0.00461	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—bone cancer	0.000423	0.00453	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—bone cancer	0.000419	0.00449	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000416	0.00446	CcSEcCtD
Alfuzosin—Abdominal pain upper—Doxorubicin—bone cancer	0.000416	0.00446	CcSEcCtD
Alfuzosin—Angina pectoris—Epirubicin—bone cancer	0.000414	0.00445	CcSEcCtD
Alfuzosin—Breast disorder—Doxorubicin—bone cancer	0.000412	0.00442	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00041	0.0044	CcSEcCtD
Alfuzosin—Bronchitis—Epirubicin—bone cancer	0.000409	0.00439	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000407	0.00436	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—bone cancer	0.000405	0.00435	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—bone cancer	0.000405	0.00435	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—bone cancer	0.000405	0.00435	CcSEcCtD
Alfuzosin—Pain—Cisplatin—bone cancer	0.000403	0.00432	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Epirubicin—bone cancer	0.000395	0.00424	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—bone cancer	0.000389	0.00417	CcSEcCtD
Alfuzosin—Feeling abnormal—Cisplatin—bone cancer	0.000388	0.00417	CcSEcCtD
Alfuzosin—Angina pectoris—Doxorubicin—bone cancer	0.000384	0.00411	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—bone cancer	0.000383	0.00411	CcSEcCtD
Alfuzosin—Infestation NOS—Epirubicin—bone cancer	0.000379	0.00407	CcSEcCtD
Alfuzosin—Infestation—Epirubicin—bone cancer	0.000379	0.00407	CcSEcCtD
Alfuzosin—Drowsiness—Epirubicin—bone cancer	0.000379	0.00407	CcSEcCtD
Alfuzosin—Bronchitis—Doxorubicin—bone cancer	0.000379	0.00406	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Epirubicin—bone cancer	0.000372	0.00399	CcSEcCtD
Alfuzosin—Jaundice—Epirubicin—bone cancer	0.00037	0.00397	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000366	0.00393	CcSEcCtD
Alfuzosin—Sweating—Epirubicin—bone cancer	0.000364	0.0039	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—bone cancer	0.000361	0.00388	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—bone cancer	0.000359	0.00386	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Epirubicin—bone cancer	0.000359	0.00385	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—bone cancer	0.000357	0.00383	CcSEcCtD
Alfuzosin—Sinusitis—Epirubicin—bone cancer	0.000356	0.00382	CcSEcCtD
Alfuzosin—Infestation NOS—Doxorubicin—bone cancer	0.000351	0.00377	CcSEcCtD
Alfuzosin—Infestation—Doxorubicin—bone cancer	0.000351	0.00377	CcSEcCtD
Alfuzosin—Drowsiness—Doxorubicin—bone cancer	0.000351	0.00377	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000344	0.00369	CcSEcCtD
Alfuzosin—Jaundice—Doxorubicin—bone cancer	0.000342	0.00367	CcSEcCtD
Alfuzosin—Rhinitis—Epirubicin—bone cancer	0.000341	0.00366	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—bone cancer	0.00034	0.00365	CcSEcCtD
Alfuzosin—Asthenia—Cisplatin—bone cancer	0.000338	0.00363	CcSEcCtD
Alfuzosin—Pharyngitis—Epirubicin—bone cancer	0.000338	0.00363	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—bone cancer	0.000338	0.00362	CcSEcCtD
Alfuzosin—Sweating—Doxorubicin—bone cancer	0.000337	0.00361	CcSEcCtD
Alfuzosin—Urinary tract disorder—Epirubicin—bone cancer	0.000336	0.00361	CcSEcCtD
Alfuzosin—Connective tissue disorder—Epirubicin—bone cancer	0.000335	0.00359	CcSEcCtD
Alfuzosin—Urethral disorder—Epirubicin—bone cancer	0.000334	0.00358	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000332	0.00356	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—bone cancer	0.00033	0.00354	CcSEcCtD
Alfuzosin—Sinusitis—Doxorubicin—bone cancer	0.000329	0.00353	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—bone cancer	0.000328	0.00352	CcSEcCtD
Alfuzosin—Diarrhoea—Cisplatin—bone cancer	0.000322	0.00346	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—bone cancer	0.000319	0.00342	CcSEcCtD
Alfuzosin—Eye disorder—Epirubicin—bone cancer	0.000318	0.00341	CcSEcCtD
Alfuzosin—Cardiac disorder—Epirubicin—bone cancer	0.000316	0.00339	CcSEcCtD
Alfuzosin—Flushing—Epirubicin—bone cancer	0.000316	0.00339	CcSEcCtD
Alfuzosin—Rhinitis—Doxorubicin—bone cancer	0.000316	0.00339	CcSEcCtD
Alfuzosin—Pharyngitis—Doxorubicin—bone cancer	0.000313	0.00336	CcSEcCtD
Alfuzosin—Urinary tract disorder—Doxorubicin—bone cancer	0.000311	0.00334	CcSEcCtD
Alfuzosin—Connective tissue disorder—Doxorubicin—bone cancer	0.00031	0.00332	CcSEcCtD
Alfuzosin—Angiopathy—Epirubicin—bone cancer	0.000309	0.00332	CcSEcCtD
Alfuzosin—Urethral disorder—Doxorubicin—bone cancer	0.000309	0.00331	CcSEcCtD
Alfuzosin—Mediastinal disorder—Epirubicin—bone cancer	0.000307	0.00329	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—bone cancer	0.000306	0.00329	CcSEcCtD
Alfuzosin—Vomiting—Cisplatin—bone cancer	0.0003	0.00321	CcSEcCtD
Alfuzosin—Mental disorder—Epirubicin—bone cancer	0.000298	0.0032	CcSEcCtD
Alfuzosin—Rash—Cisplatin—bone cancer	0.000297	0.00319	CcSEcCtD
Alfuzosin—Dermatitis—Cisplatin—bone cancer	0.000297	0.00318	CcSEcCtD
Alfuzosin—Eye disorder—Doxorubicin—bone cancer	0.000295	0.00316	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—bone cancer	0.000294	0.00315	CcSEcCtD
Alfuzosin—Cardiac disorder—Doxorubicin—bone cancer	0.000292	0.00314	CcSEcCtD
Alfuzosin—Flushing—Doxorubicin—bone cancer	0.000292	0.00314	CcSEcCtD
Alfuzosin—Back pain—Epirubicin—bone cancer	0.000287	0.00308	CcSEcCtD
Alfuzosin—Angiopathy—Doxorubicin—bone cancer	0.000286	0.00307	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—bone cancer	0.000286	0.00306	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—bone cancer	0.000285	0.00305	CcSEcCtD
Alfuzosin—Mediastinal disorder—Doxorubicin—bone cancer	0.000284	0.00305	CcSEcCtD
Alfuzosin—Nausea—Cisplatin—bone cancer	0.00028	0.003	CcSEcCtD
Alfuzosin—Mental disorder—Doxorubicin—bone cancer	0.000276	0.00296	CcSEcCtD
Alfuzosin—Ill-defined disorder—Epirubicin—bone cancer	0.000275	0.00295	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—bone cancer	0.00027	0.00289	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—bone cancer	0.00027	0.00289	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000268	0.00287	CcSEcCtD
Alfuzosin—Malaise—Epirubicin—bone cancer	0.000267	0.00287	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—bone cancer	0.000266	0.00286	CcSEcCtD
Alfuzosin—Vertigo—Epirubicin—bone cancer	0.000266	0.00286	CcSEcCtD
Alfuzosin—Syncope—Epirubicin—bone cancer	0.000266	0.00285	CcSEcCtD
Alfuzosin—Back pain—Doxorubicin—bone cancer	0.000265	0.00285	CcSEcCtD
Alfuzosin—Palpitations—Epirubicin—bone cancer	0.000262	0.00281	CcSEcCtD
Alfuzosin—Loss of consciousness—Epirubicin—bone cancer	0.000261	0.0028	CcSEcCtD
Alfuzosin—Infection—Methotrexate—bone cancer	0.000257	0.00276	CcSEcCtD
Alfuzosin—Ill-defined disorder—Doxorubicin—bone cancer	0.000255	0.00273	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—bone cancer	0.000254	0.00272	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—bone cancer	0.000253	0.00272	CcSEcCtD
Alfuzosin—Arthralgia—Epirubicin—bone cancer	0.000252	0.00271	CcSEcCtD
Alfuzosin—Chest pain—Epirubicin—bone cancer	0.000252	0.00271	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—bone cancer	0.000251	0.00269	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000251	0.00269	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—bone cancer	0.00025	0.00268	CcSEcCtD
Alfuzosin—Discomfort—Epirubicin—bone cancer	0.000249	0.00268	CcSEcCtD
Alfuzosin—Malaise—Doxorubicin—bone cancer	0.000247	0.00265	CcSEcCtD
Alfuzosin—Dry mouth—Epirubicin—bone cancer	0.000247	0.00265	CcSEcCtD
Alfuzosin—Vertigo—Doxorubicin—bone cancer	0.000246	0.00264	CcSEcCtD
Alfuzosin—Syncope—Doxorubicin—bone cancer	0.000246	0.00264	CcSEcCtD
Alfuzosin—Palpitations—Doxorubicin—bone cancer	0.000242	0.0026	CcSEcCtD
Alfuzosin—Oedema—Epirubicin—bone cancer	0.000242	0.0026	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—bone cancer	0.000242	0.00259	CcSEcCtD
Alfuzosin—Loss of consciousness—Doxorubicin—bone cancer	0.000241	0.00259	CcSEcCtD
Alfuzosin—Infection—Epirubicin—bone cancer	0.00024	0.00258	CcSEcCtD
Alfuzosin—Shock—Epirubicin—bone cancer	0.000238	0.00255	CcSEcCtD
Alfuzosin—Nervous system disorder—Epirubicin—bone cancer	0.000237	0.00255	CcSEcCtD
Alfuzosin—Thrombocytopenia—Epirubicin—bone cancer	0.000237	0.00254	CcSEcCtD
Alfuzosin—Tachycardia—Epirubicin—bone cancer	0.000236	0.00253	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000236	0.00253	CcSEcCtD
Alfuzosin—Skin disorder—Epirubicin—bone cancer	0.000235	0.00252	CcSEcCtD
Alfuzosin—Hyperhidrosis—Epirubicin—bone cancer	0.000234	0.00251	CcSEcCtD
Alfuzosin—Chest pain—Doxorubicin—bone cancer	0.000234	0.00251	CcSEcCtD
Alfuzosin—Arthralgia—Doxorubicin—bone cancer	0.000234	0.00251	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000232	0.00249	CcSEcCtD
Alfuzosin—Discomfort—Doxorubicin—bone cancer	0.000231	0.00248	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—bone cancer	0.00023	0.00247	CcSEcCtD
Alfuzosin—Dry mouth—Doxorubicin—bone cancer	0.000228	0.00245	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—bone cancer	0.000228	0.00244	CcSEcCtD
Alfuzosin—Hypotension—Epirubicin—bone cancer	0.000226	0.00243	CcSEcCtD
Alfuzosin—Oedema—Doxorubicin—bone cancer	0.000224	0.0024	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000223	0.00239	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—bone cancer	0.000223	0.00239	CcSEcCtD
Alfuzosin—Infection—Doxorubicin—bone cancer	0.000222	0.00239	CcSEcCtD
Alfuzosin—Pain—Methotrexate—bone cancer	0.000221	0.00237	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00022	0.00237	CcSEcCtD
Alfuzosin—Shock—Doxorubicin—bone cancer	0.00022	0.00236	CcSEcCtD
Alfuzosin—Nervous system disorder—Doxorubicin—bone cancer	0.00022	0.00236	CcSEcCtD
Alfuzosin—Thrombocytopenia—Doxorubicin—bone cancer	0.000219	0.00235	CcSEcCtD
Alfuzosin—Tachycardia—Doxorubicin—bone cancer	0.000219	0.00234	CcSEcCtD
Alfuzosin—Skin disorder—Doxorubicin—bone cancer	0.000217	0.00233	CcSEcCtD
Alfuzosin—Hyperhidrosis—Doxorubicin—bone cancer	0.000216	0.00232	CcSEcCtD
Alfuzosin—Somnolence—Epirubicin—bone cancer	0.000215	0.00231	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—bone cancer	0.000213	0.00229	CcSEcCtD
Alfuzosin—Dyspepsia—Epirubicin—bone cancer	0.000213	0.00229	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—bone cancer	0.000211	0.00227	CcSEcCtD
Alfuzosin—Hypotension—Doxorubicin—bone cancer	0.000209	0.00224	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000209	0.00224	CcSEcCtD
Alfuzosin—Fatigue—Epirubicin—bone cancer	0.000209	0.00224	CcSEcCtD
Alfuzosin—Pain—Epirubicin—bone cancer	0.000207	0.00222	CcSEcCtD
Alfuzosin—Constipation—Epirubicin—bone cancer	0.000207	0.00222	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—bone cancer	0.000205	0.0022	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—bone cancer	0.000204	0.00219	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000204	0.00219	CcSEcCtD
Alfuzosin—Feeling abnormal—Epirubicin—bone cancer	0.000199	0.00214	CcSEcCtD
Alfuzosin—Somnolence—Doxorubicin—bone cancer	0.000199	0.00214	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Epirubicin—bone cancer	0.000198	0.00212	CcSEcCtD
Alfuzosin—Dyspepsia—Doxorubicin—bone cancer	0.000197	0.00211	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000193	0.00207	CcSEcCtD
Alfuzosin—Fatigue—Doxorubicin—bone cancer	0.000193	0.00207	CcSEcCtD
Alfuzosin—Urticaria—Epirubicin—bone cancer	0.000192	0.00206	CcSEcCtD
Alfuzosin—Constipation—Doxorubicin—bone cancer	0.000191	0.00205	CcSEcCtD
Alfuzosin—Pain—Doxorubicin—bone cancer	0.000191	0.00205	CcSEcCtD
Alfuzosin—Abdominal pain—Epirubicin—bone cancer	0.000191	0.00205	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—bone cancer	0.000186	0.00199	CcSEcCtD
Alfuzosin—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.00198	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000183	0.00196	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—bone cancer	0.000183	0.00196	CcSEcCtD
Alfuzosin—Urticaria—Doxorubicin—bone cancer	0.000178	0.00191	CcSEcCtD
Alfuzosin—Abdominal pain—Doxorubicin—bone cancer	0.000177	0.0019	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—bone cancer	0.000177	0.0019	CcSEcCtD
Alfuzosin—Asthenia—Epirubicin—bone cancer	0.000174	0.00186	CcSEcCtD
Alfuzosin—Pruritus—Epirubicin—bone cancer	0.000171	0.00184	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—bone cancer	0.000171	0.00183	CcSEcCtD
Alfuzosin—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00178	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—bone cancer	0.000164	0.00176	CcSEcCtD
Alfuzosin—Rash—Methotrexate—bone cancer	0.000163	0.00175	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—bone cancer	0.000163	0.00175	CcSEcCtD
Alfuzosin—Headache—Methotrexate—bone cancer	0.000162	0.00174	CcSEcCtD
Alfuzosin—Asthenia—Doxorubicin—bone cancer	0.000161	0.00172	CcSEcCtD
Alfuzosin—Dizziness—Epirubicin—bone cancer	0.00016	0.00172	CcSEcCtD
Alfuzosin—Pruritus—Doxorubicin—bone cancer	0.000158	0.0017	CcSEcCtD
Alfuzosin—Vomiting—Epirubicin—bone cancer	0.000154	0.00165	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—bone cancer	0.000154	0.00165	CcSEcCtD
Alfuzosin—Diarrhoea—Doxorubicin—bone cancer	0.000153	0.00164	CcSEcCtD
Alfuzosin—Rash—Epirubicin—bone cancer	0.000153	0.00164	CcSEcCtD
Alfuzosin—Dermatitis—Epirubicin—bone cancer	0.000152	0.00164	CcSEcCtD
Alfuzosin—Headache—Epirubicin—bone cancer	0.000152	0.00163	CcSEcCtD
Alfuzosin—Dizziness—Doxorubicin—bone cancer	0.000148	0.00159	CcSEcCtD
Alfuzosin—Nausea—Epirubicin—bone cancer	0.000144	0.00154	CcSEcCtD
Alfuzosin—Vomiting—Doxorubicin—bone cancer	0.000142	0.00153	CcSEcCtD
Alfuzosin—Rash—Doxorubicin—bone cancer	0.000141	0.00151	CcSEcCtD
Alfuzosin—Dermatitis—Doxorubicin—bone cancer	0.000141	0.00151	CcSEcCtD
Alfuzosin—Headache—Doxorubicin—bone cancer	0.00014	0.0015	CcSEcCtD
Alfuzosin—Nausea—Doxorubicin—bone cancer	0.000133	0.00143	CcSEcCtD
